Application Progress and Optimization of Probiotics and Prebiotics in Chronic Diseases
DOI:
https://doi.org/10.61173/ahbzed55Keywords:
Probiotics, chronic illnesses, Lactobacillus plantarum, gut microor-ganisms, phenol high-through-put screeningAbstract
The increasing prevalence of chronic illnesses can be attributed to modern unhealthy lifestyle habits, sparking significant interest in the role of probiotics in supporting gut health. Research has demonstrated the potential of probiotics to balance gut microbiota, leading to their application in functional foods. However, challenges remain, including ensuring the probiotics’ survival through the gastrointestinal tract and their absorption once they reach the gut. This article explores the relationship between probiotics and the human gut microbiome, with a focus on how dietary habits influence gut health. Furthermore, it discusses the mutagenesis of Lactobacillus plantarum and the application of these mutant probiotics in the treatment of hyperuricemia (HUA) and gout. A phenol high-throughput screening method is presented for identifying mutant probiotics, offering insights into more effective probiotic mutagenesis and screening techniques. Future research should aim to verify the success of probiotic mutations and focus on improving methodologies for probiotic development and delivery
References
[1] China Association for Probiotics, Chinese Institute of Food Science and Technology. “Expert Consensus on the Main Characteristics of Human Intestinal Microbiota.” Journal of Chinese Institute of Food Science and Technology, vol. 24, no. 7, 2024, pp. 460-470.
[2] Liu, Y. F. “Research Progress on Probiotic Health Foods.” China Food Industry, no. 9, 2024, pp. 162-164.
[3] Yu, C. Q., Zhang, L. N., and Deng, X. M. “UV Mutation Breeding of Cholesterol-Lowering Lactobacillus Plantarum.” Microbiology Bulletin, vol. 9, 2008, pp. 1461-1465. Retrieved on September 11, 2023.
[4] Joshi, D. S., Singhvi, M. S., Khire, J. M., and Gokhale, D. V. “Strain Improvement of Lactobacillus lactis for D-Lactic Acid Production.” Biotechnology Letters, vol. 32, no. 4, 2010, pp. 517-520.
[5] Laboni Akter. Probiotics and Chronic Diseases: A Systematic Review of Bibliometric Analysis and Systematic Evaluation [D]. null, 2019.
[6] Zhang, Q., Yang, H., and Su, D. “Role of Prebiotics in Chronic Disease Prevention.” Food Safety Guide, 2018, no. 101, pp. 68-69.
[7] Turnbaugh, P. J., Ley, R. E., Hamady, M., et al. “The Human Microbiome Project.” Nature, vol. 449, no. 7164, 2007, pp. 804- 810.
[8] Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., et al. “Human Gut Microbiota in Health and Disease: Unveiling the Relationship.” Frontiers in Microbiology, vol. 13, 2022.
[9] He, S. Effects of High-Fat and High-Salt Diet on Intestinal Microecology and Bile Acid Metabolism [D]. Tianjin University of Science and Technology, 2022.
[10] Yun, S., Seo, Y., Lee, Y., and Lee, D. T. “Gut Microbiome Related to Metabolic Diseases after Moderate-to-Vigorous Intensity Exercise.” Journal of Exercise Science & Fitness, vol. 22, no. 4, 2024, pp. 375-382.
[11] Johannesson, E., Simren, M., Strid, H., Bajor, A., and Sadik, R. “Physical Activity Improves Symptoms in Irritable Bowel Syndrome: A Randomized Controlled Trial.” American Journal of Gastroenterology, vol. 106, 2011, pp. 915–922.
[12] Lin, K. Y., Shun, S. C., Lai, Y. H., Liang, J. T., and Tsauo, J. Y. “Comparison of the Effects of a Supervised Exercise Program and Usual Care in Patients with Colorectal Cancer Undergoing Chemotherapy.” Cancer Nursing, vol. 37, 2014, pp. E21–E29.
[13] Lund, K., Knudsen, T., Kjeldsen, J., Nielsen, R. G., Juhl, C. B., and Norgard, B. M. “The IBD-FITT Study - Moderate- Intensity Exercise for Patients with Inflammatory Bowel Disease with Moderate Disease Activity: An Open-Label Randomized Controlled Trial.” Trials, vol. 24, 2023, p. 742.
[14] American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription. 11th ed., Wolters Kluwer, 2021.
[15] Ramasamy, S. N., et al. “Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950-2012.” Drug Dean&Francis Zijian Qiu Safety, vol. 36, no. 10, 2013, pp. 953–980.
[16] Azevedo, V. F., Kos, I. A., Vargas-Santos, A. B., Pinheiro, G. da R. C., and Paiva, E. dos S. “Benzbromarone in the Treatment of Gout.” Advances in Rheumatology, vol. 59, no. 1, 2019, p. 37.
[17] Brinques, G. B., Peralba, M. do C., and Ayub, M. A. Z. “Optimization of Probiotic and Lactic Acid Production by Lactobacillus Plantarum in Submerged Bioreactor Systems.” Journal of Industrial Microbiology & Biotechnology, vol. 37, no. 2, 2010, pp. 205–212.
[18] Xue, Z. P., Wang, Z., Pan, D., et al. “Mechanism and Research Progress of Probiotics in the Treatment and Alleviation of Constipation.” Food Research and Development, vol. 43, no. 12, 2022, pp. 204-209.
[19] Tan, F., Zhou, X., Ren, L., and Kong, C.-S. “Effect of Lactiplantibacillus plantatum HFY11 on Colitis in Mice.” Foods, vol. 13, no. 1496, 2024.
[20] Song, J. “Functional Properties of Probiotics in Food Sources.” Foods (Basel, Switzerland), vol. 13, no. 16, 2024, p. 2548.
[21] Zeng, C. “Observation on the Efficacy of Yakult Combined with Triple Therapy in the Treatment of Helicobacter Pylori Positive Peptic Ulcer.” Modern Digestive and Interventional Diagnosis and Treatment, vol. 22, no. 3, 2017, pp. 413-414.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
